Pain in the Neck (7.28.2023)

This week, discussions reveal alarming misdiagnosis rates in the U.S. and their severe health implications. The episode delves into how cost-related non-adherence affects lupus treatment outcomes. The landscape of arthritis treatment is evolving with discussions on biosimilars and IL-1 inhibitors. Recent advancements in gout therapies include SGLT2 inhibitors, while complications in diagnosing calcium pyrophosphate deposition disease are explored. Treatment options for rheumatoid nodules are reviewed, highlighting the challenges faced by rheumatologists.